Products
B2B Zone
6th DDR Inhibitors Summit
6th DDR Inhibitors Summit
Conferences

6th DDR Inhibitors Summit

By

Hanson Wade

2 Followers
24 Jan 2024 - 26 Jan 2024
Free Registration

Event Details

6th DDR Inhibitors Summit

DNA damage response inhibition has amassed a lot of interest over the last decade as it exposes a massive vulnerability in cancer cells. This has a huge potential to treat many types of tumors such as breast and colorectal cancers, and even notoriously difficult-to-treat CNS tumors.

The 6th Annual DDR Inhibitors Summit will cover both the preclinical and clinical DDR inhibitor landscape and establish how the field is addressing the biggest hurdle to drug development – toxicity. From reviewing progress with both novel and established targets to utilizing inhibitors in combination studies and improving patient selection with improved biomarkers; this meeting will give a comprehensive and up-to-date overview of the field.

As we look to 2023 and what it has in store, this highly anticipated summit is back in person, bigger and better than ever before. As the industry-leading conference, join forward-thinking researchers from the pharmaceutical, biotech and academic community as they unite to share ideas on progress, challenges and novel solutions in the current DDRi climate.

Prices:
FULL PACKAGE: Conference + Pre-Conference Day - Drug Developer USD 4946.00
Conference Only - Drug Developer USD 2999.00
FULL PACKAGE: Conference + Pre-Conference Day - Academic USD 4246.00
Conference Only - Academic USD 2599.00
FULL PACKAGE: Conference + Pre-Conference Day - Solution Provider USD 5846.00
Conference Only - Solution Provider USD 3599.00

Speakers: Anang Shelat, Professor & Director - Compound Management & Discovery Informatics Lead, St. Jude Children’s Research Hospital, Arne Nedergaard, Koshoult Postdoc, The Netherlands Cancer Institute, Asli Muffavak, Associate Director - Scientific, Oncology, Synthetic & Lethality, GlaxoSmithKline, Charles Sinclair, Head of Translational Sciences, Pioneering Medicines, Flagship Pioneering, Chun-Pyn, Shen Vice President & Head of Regulatory Affairs, IMPACT Therapeutics, David Mankoff, Co-founder, Perelman School of Medicine at the University of Pennsylvania, Eric Brown, Co-Founder, Aprea Therapeutics, Erik Sulman, Co-Director, Brain Tumor Center, NYU Langone, Frank Zenke, Global Head DNA Damage Response Research, Translational Innovation Platform Oncology and Immuno- Oncology, EMD Serano Inc., Geoffrey Shapiro, Director, Early Drug Development Center, Dana-Farber Cancer Institute, Greg Korbel, Chief Operating Officer, Aprea Therapeutics, Ioannis Gounaris, Head of Clinical Development DDR, Merck KGaA, Jann Sarkaria, Professor - Radiation Oncology, Mayo Clinic, Jennifer Castro, Principal Scientist, Accent Therapeutics, Jing Li, Professor of Oncology & Director of Pharmacology & Metabolomics Core Wayne State, University School of Medicine, Jon Hollick, Managing Director & Head of Research, Breakpoint Therapeutics, Kara Machleidt, Global Commercialization Marketing Manager, Promega, Kieran Pinto, DDR Analyst, Beacon Intelligence, Kirk Tanner, Chief Scientific Officer, National Brain Tumor Society, Mads Daugaard, President & Chief Scientific Officer, Rakovina Therapeutics, Mark O’Connor, Chief Scientist, Early Oncology Discovery, AstraZeneca, Nader Sanai, Chief Scientific Officer & Director, Ivy Brain Tumor Centre, Nimrat Chatterjee, Assistant Professor, University of Vermont, Cancer Center, Oren Gilad, Chief Executive Officer, Aprea Therapeutics, Paul Bartell, Senior Vice-President, Companian Diagnostics, Myriad Genetics, Ranjit Bindra, Co-Founder, Modifi Bio, Sotirios Sortirou, Head of Biology & Co- Founder, FoRx Therapeutics, Steve Warner, Senior Vice President & Head of US Research, Sumitomo Pharma Oncology, Sui Xiong Cai, Senior Vice President & Chief Technology Officer Oncology, IMPACT Therapeutics, Timothy Yap, Medical Director, MD Anderson Cancer Centre, Wael Jdey, Head of In Vitro Oncology Research & Innovation Group, Onxeo

Entry Fees

Free Registration

Categories

Event Frequency

One Time

Event Timings

(GMT-5:00) Central Time (US and Canada)
09:00 AM - 06:00 PM (Jan 24, Jan 25, Jan 26) (General)

Comments on 6th DDR Inhibitors Summit

You must to write a comment.

Peoples Interested in Visit

0 Peoples Interested to Visit

Event Location

Crowne Plaza Boston - Woburn, an IHG Hotel
15, Middlesex Canal Park Drive, Woburn ,
Middlesex County 01801, Massachusetts, United States
Official Link :

More Events By Organizer

2nd Covalent Drug Discovery and Development Summit
2nd Covalent Drug Discovery and Development Summit
10
Dec
2024
Free
Conferences
Patient Recruitment for Rare Disease Trials Summit 2024
Patient Recruitment for Rare Disease Trials Summit 2024
10
Dec
2024
Free
Conferences
7th RNA-Targeted Drug Discovery and Development Summit
7th RNA-Targeted Drug Discovery and Development Summit
10
Dec
2024
Free
Conferences
EHS and S for Biopharma and Pharma Summit West
EHS and S for Biopharma and Pharma Summit West
10
Dec
2024

EHS and S for Biopharma and Pharma Summit West

San Diego County, United States
Free
Conferences
4th Rare and Genetic Kidney Disease Drug Development Summit
4th Rare and Genetic Kidney Disease Drug Development Summit
10
Dec
2024
3rd LNP Immunogenicity and Toxicity Summit
3rd LNP Immunogenicity and Toxicity Summit
09
Dec
2024

3rd LNP Immunogenicity and Toxicity Summit

Suffolk County, United States
Free
Conferences

Similar Events

19. AIO-Herbstkongress 2022 - Update Medical Oncology
19. AIO-Herbstkongress 2022 - Update Medical Oncology
08
Dec
2022
4th Targeted Radiopharmaceuticals Europe
4th Targeted Radiopharmaceuticals Europe
06
Dec
2022
Free
Conferences
Multidisciplinary Update in Breast Disease 2023
Multidisciplinary Update in Breast Disease 2023
09
Nov
2023
Free
Conferences
20th Annual Mayo Clinic Hematology Review 2023
20th Annual Mayo Clinic Hematology Review 2023
28
Jan
2023
Free
Conferences
50th ECTS Congress feat. BRS Annual Meeting 2023, Liverpool
50th ECTS Congress feat. BRS Annual Meeting 2023, Liverpool
15
Apr
2023
Free
Conferences
17th International Congress on Myelodysplastic Syndromes
17th International Congress on Myelodysplastic Syndromes
03
May
2023
Free
Conferences
Benefits of Signin
  • Publish Your Event for Free
  • Find Upcoming Events Near By
  • Grow Your B2B Network
  • Fix B2B Meeting Online/Event
  • Showcase Products to Right People